+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Minimal Residual Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CAR-T - Pipeline Insight, 2025 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Penile Cancer Market Report 2025 - Product Thumbnail Image

Penile Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market Report 2025 - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Soft Tissue Sarcoma Market Report 2025 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Bone Cancer Treatment Market Report 2025 - Product Thumbnail Image

Bone Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
From
Loading Indicator